ArticleOncoimmunology2016

MHC class II tetramer analyses in AE37-vaccinated prostate cancer patients reveal vaccine-specific polyfunctional and long-lasting CD4(+) T-cells.

Eleftheria A Anastasopoulou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.